Wigge & Partners advised Saminvest on its 25 MEUR cornerstone investment

07 January 2022

Wigge & Partners is happy to have advised Saminvest on its 25 MEUR cornerstone investment into the first closing of Sound Bioventures, a newly established biotech fund with a focus on companies developing treatment options for rare diseases. Saminvest’s investment is part of its objective to increase available capital for Swedish start-ups.